114 related articles for article (PubMed ID: 20378736)
1. Effects of a beta-blocker on the cardiovascular response to MDMA (Ecstasy).
Hysek CM; Vollenweider FX; Liechti ME
Emerg Med J; 2010 Aug; 27(8):586-9. PubMed ID: 20378736
[TBL] [Abstract][Full Text] [Related]
2. Effects of the α₂-adrenergic agonist clonidine on the pharmacodynamics and pharmacokinetics of 3,4-methylenedioxymethamphetamine in healthy volunteers.
Hysek CM; Brugger R; Simmler LD; Bruggisser M; Donzelli M; Grouzmann E; Hoener MC; Liechti ME
J Pharmacol Exp Ther; 2012 Feb; 340(2):286-94. PubMed ID: 22034656
[TBL] [Abstract][Full Text] [Related]
3. The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans.
Hysek CM; Simmler LD; Ineichen M; Grouzmann E; Hoener MC; Brenneisen R; Huwyler J; Liechti ME
Clin Pharmacol Ther; 2011 Aug; 90(2):246-55. PubMed ID: 21677639
[TBL] [Abstract][Full Text] [Related]
4. α₁-Adrenergic receptors contribute to the acute effects of 3,4-methylenedioxymethamphetamine in humans.
Hysek CM; Fink AE; Simmler LD; Donzelli M; Grouzmann E; Liechti ME
J Clin Psychopharmacol; 2013 Oct; 33(5):658-66. PubMed ID: 23857311
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans.
Mas M; Farré M; de la Torre R; Roset PN; Ortuño J; Segura J; Camí J
J Pharmacol Exp Ther; 1999 Jul; 290(1):136-45. PubMed ID: 10381769
[TBL] [Abstract][Full Text] [Related]
6. Ethanol co-administration moderates 3,4-methylenedioxymethamphetamine effects on human physiology.
Dumont GJ; Kramers C; Sweep FC; Willemsen JJ; Touw DJ; Schoemaker RC; van Gerven JM; Buitelaar JK; Verkes RJ
J Psychopharmacol; 2010 Feb; 24(2):165-74. PubMed ID: 19074534
[TBL] [Abstract][Full Text] [Related]
7. Cannabis coadministration potentiates the effects of "ecstasy" on heart rate and temperature in humans.
Dumont GJ; Kramers C; Sweep FC; Touw DJ; van Hasselt JG; de Kam M; van Gerven JM; Buitelaar JK; Verkes RJ
Clin Pharmacol Ther; 2009 Aug; 86(2):160-6. PubMed ID: 19440186
[TBL] [Abstract][Full Text] [Related]
8. Safety pharmacology of acute MDMA administration in healthy subjects.
Vizeli P; Liechti ME
J Psychopharmacol; 2017 May; 31(5):576-588. PubMed ID: 28443695
[TBL] [Abstract][Full Text] [Related]
9. Effects of beta-adrenoceptor blocking agents, pindolol, alprenolol and practolol on blood pressure and heart rate in conscious renal hypertensive dogs.
Himori N; Ishimori T; Izumi A; Hiramatsu Y
Arch Int Pharmacodyn Ther; 1977 Jan; 225(1):152-65. PubMed ID: 15525
[TBL] [Abstract][Full Text] [Related]
10. Investigation of serotonin-1A receptor function in the human psychopharmacology of MDMA.
Hasler F; Studerus E; Lindner K; Ludewig S; Vollenweider FX
J Psychopharmacol; 2009 Nov; 23(8):923-35. PubMed ID: 18635693
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of 3,4-methylenedioxymethamphetamine. A double-blind, placebo-controlled trial.
Lester SJ; Baggott M; Welm S; Schiller NB; Jones RT; Foster E; Mendelson J
Ann Intern Med; 2000 Dec; 133(12):969-73. PubMed ID: 11119398
[TBL] [Abstract][Full Text] [Related]
12. [Effects of beta-blockers on hemodynamics of the forearm after tobacco stimulation].
Girerd X; Brunel P; Laurent S; Pannier B; Isnard R; Safar M
Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():133-6. PubMed ID: 2903727
[TBL] [Abstract][Full Text] [Related]
13. Vasodilatory effects of carvedilol and pindolol.
Sundberg S; Tiihonen K; Gordin A
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S76-80. PubMed ID: 2454373
[TBL] [Abstract][Full Text] [Related]
14. Influence of beta-blockade with beta-1-selectivity or intrinsic sympathomimetic activity on some cardiorespiratory responses to exercise.
Yonga GO; Oyuga HW; Njeru EK
East Afr Med J; 1993 Jul; 70(7):405-8. PubMed ID: 7904931
[TBL] [Abstract][Full Text] [Related]
15. Blockade of 5-HT2 receptor selectively prevents MDMA-induced verbal memory impairment.
van Wel JH; Kuypers KP; Theunissen EL; Bosker WM; Bakker K; Ramaekers JG
Neuropsychopharmacology; 2011 Aug; 36(9):1932-9. PubMed ID: 21562484
[TBL] [Abstract][Full Text] [Related]
16. Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans.
Hysek C; Schmid Y; Rickli A; Simmler LD; Donzelli M; Grouzmann E; Liechti ME
Br J Pharmacol; 2012 Aug; 166(8):2277-88. PubMed ID: 22404145
[TBL] [Abstract][Full Text] [Related]
17. Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naïve healthy volunteers.
Vollenweider FX; Gamma A; Liechti M; Huber T
Neuropsychopharmacology; 1998 Oct; 19(4):241-51. PubMed ID: 9718588
[TBL] [Abstract][Full Text] [Related]
18. Acute psychomotor effects of MDMA and ethanol (co-) administration over time in healthy volunteers.
Dumont GJ; Schoemaker RC; Touw DJ; Sweep FC; Buitelaar JK; van Gerven JM; Verkes RJ
J Psychopharmacol; 2010 Feb; 24(2):155-64. PubMed ID: 19164498
[TBL] [Abstract][Full Text] [Related]
19. 3,4-Methylenedioxymethamphetamine- and 8-hydroxy-2-di-n-propylamino-tetralin-induced hypothermia: role and location of 5-hydroxytryptamine 1A receptors.
Rusyniak DE; Zaretskaia MV; Zaretsky DV; DiMicco JA
J Pharmacol Exp Ther; 2007 Nov; 323(2):477-87. PubMed ID: 17702902
[TBL] [Abstract][Full Text] [Related]
20. Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans.
Liechti ME; Vollenweider FX
Eur Neuropsychopharmacol; 2000 Jul; 10(4):289-95. PubMed ID: 10871712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
